Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Endocrine 1

Conditions

Colorectal Neoplasms 5Colonic Neoplasms 5Rectal Neoplasms 4Neoplasm Metastasis 4Neoplasms 3Carcinoma, Hepatocellular 2Bile Duct Neoplasms 2Vipoma 1Stomach Neoplasms 1Stage IV Fallopian Tube Cancer AJCC v6 and v7 1Somatostatinoma 1Pseudomyxoma Peritonei 1Pheochromocytoma 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Unknown Primary 1Liver Neoplasms 1Insulinoma 1Hyperthermia 1Glucagonoma 1Genetic Diseases, Inborn 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Gastrinoma 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Cirrhosis, Familial, with Pulmonary Hypertension 1Cholangiocarcinoma 1Carcinoma, Islet Cell 1Appendiceal Neoplasms 1

Interventions

Floxuridine 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Cirrhosis, Familial, with Pulmonary Hypertension × Floxuridine × Clear all
NCT05286814 2026-05-04

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
70 enrolled
EndocrineGastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Bile Duct Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡